Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Change in Cash (2019 - 2025)

Volitionrx (VNRX) has disclosed Change in Cash for 9 consecutive years, with -$2.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Cash fell 251.68% year-over-year to -$2.1 million, compared with a TTM value of -$5.2 million through Sep 2025, up 3.33%, and an annual FY2024 reading of -$17.5 million, down 277.08% over the prior year.
  • Change in Cash was -$2.1 million for Q3 2025 at Volitionrx, down from -$344346.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $13.6 million in Q1 2021 and bottomed at -$9.0 million in Q1 2024.
  • Average Change in Cash over 5 years is -$1.0 million, with a median of -$2.1 million recorded in 2025.
  • The sharpest move saw Change in Cash surged 372.56% in 2021, then plummeted 2742.02% in 2023.
  • Year by year, Change in Cash stood at -$2.3 million in 2021, then plummeted by 139.13% to -$5.5 million in 2022, then skyrocketed by 278.79% to $9.9 million in 2023, then tumbled by 121.67% to -$2.1 million in 2024, then grew by 4.33% to -$2.1 million in 2025.
  • Business Quant data shows Change in Cash for VNRX at -$2.1 million in Q3 2025, -$344346.0 in Q2 2025, and -$664087.0 in Q1 2025.